Cidara Therapeutics stock hits 52-week high at 90.66 USD
PositiveFinancial Markets

Cidara Therapeutics has reached a significant milestone as its stock hit a 52-week high of 90.66 USD. This achievement reflects growing investor confidence in the company's potential and its innovative approaches in the biotech sector. Such a high stock price can attract more attention from investors and analysts, potentially leading to further growth and opportunities for the company.
— Curated by the World Pulse Now AI Editorial System